Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08
Teladoc Health (NYSE:TDOC) announced an employment inducement award effective March 1, 2026, for Daniel Conroy as Chief Growth Officer, U.S. Group Health.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Teladoc Health (NYSE:TDOC) announced an employment inducement award effective March 1, 2026, for Daniel Conroy as Chief Growth Officer, U.S. Group Health. The grant includes 57,034 restricted stock units and 57,034 performance stock units (target), with up to 114,068 PSU shares earnable.
RSUs vest one-third at the first anniversary, then quarterly over two years; PSUs vest based on three-year financial metrics. The award was approved by the Compensation Committee under the 2023 Employment Inducement Incentive Award Plan per NYSE Rule 303A.08.
Details
News Market Reaction – TDOC
On Mar 5, the first trading day after this news, TDOC closed 0.19% below the previous close.
Data tracked by StockTitan Argus for the Mar 5 session.
Key Figures
- RSU grant size
- 57,034 shares
- Restricted stock units for new Chief Growth Officer, U.S. Group Health
- PSU target shares
- 57,034 shares
- Target performance stock units tied to financial metrics
- PSU maximum shares
- 114,068 shares
- Maximum earnable under performance stock unit award
- Common stock par value
- $0.001 per share
- Par value of Teladoc Health common stock
- RSU vesting period
- 3 years
- One-third after 1 year, remainder quarterly over 2 years
- PSU performance period
- 3 years
- Shares earned over three years based on financial metrics
Historical Context
-
Reported flat Q4 revenue, FY revenue decline, and improved adjusted EBITDA with outlook.
-
Added experienced financial executive Michael Smith to board and key committees.
-
Announced timing and access details for upcoming Q4 2025 earnings release call.
-
Launched enhanced 24/7 Care nationwide, broadening virtual urgent care capabilities.
-
CEO scheduled to present at J.P. Morgan Healthcare Conference with webcast access.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
restricted stock units financial
performance stock units financial
par value financial
employment inducement award financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.
Effective March 1, 2026, in connection with commencing employment as Chief Growth Officer, U.S. Group Health, Daniel Conroy was granted an award of restricted stock units covering 57,034 shares of Teladoc Health’s common stock, par value
About Teladoc Health
Teladoc Health (NYSE: TDOC) is the global leader in virtual care. The company is delivering and orchestrating care across patients, care providers, platforms, and partners — transforming virtual care into a catalyst for how better health happens. Through our relationships with health plans, employers, providers, health systems and consumers, we are enabling more access, driving better outcomes, extending provider capacity and lowering costs. Learn more at teladochealth.com.
Media:
Lou Serio
pr@teladochealth.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.